Demopulos Gregory A MD bought OMER

October 28, 2026 · Form 4 insider transaction

Demopulos Gregory A MD bought 500,000 shares of Omeros Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
500,000
Price
$0.00
Total value
N/A
Role—
SecurityPerformance Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 28, 2026
Filing dateOctober 30, 2026
Shares owned after500,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

No portion of the option was vested, and no shares were issued, on the grant date. The shares subject to the option will vest and become exercisable in four equal tranches subject to both (i) achievement of stock-price hurdles of $25.00, $30.00, $35.00 and $40.00 per share, respectively, calculated based on the aggregate volume-weighted average price of the registrant's common stock over 30 consecutive trading days, taken as a single measurement period, at any point during the option's five-year term, and (ii) satisfaction of a continued-service condition under which 25% of the shares in each tranche will become eligible for vesting on the first anniversary of the grant date and the remainder will become eligible for vesting in equal monthly installments over the following 36 months. The stock-price hurdles represent appreciation of approximately 40%, 68%, 96% and 124%, respectively, above the grant-date closing price of $17.88 per share, which is also the option's exercise price.

View the original Form 4 on SEC EDGAR